Literature DB >> 22675784

Legalization, decriminalization & medicinal use of cannabis: a scientific and public health perspective.

Dragan M Svrakic1, Patrick J Lustman, Ashok Mallya, Taylor Andrea Lynn, Rhonda Finney, Neda M Svrakic.   

Abstract

Empirical and clinical studies clearly demonstrate significant adverse effects of cannabis smoking on physical and mental health as well as its interference with social and occupational functioning. These negative data far outweigh a few documented benefits for a limited set of medical indications, for which safe and effective alternative treatments are readily available. If there is any medical role for cannabinoid drugs, it lies with chemically defined compounds, not with unprocessed cannabis plant. Legalization or medical use of smoked cannabis is likely to impose significant public health risks, including an increased risk of schizophrenia, psychosis, and other forms of substance use disorders.

Entities:  

Mesh:

Year:  2012        PMID: 22675784      PMCID: PMC6181739     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  37 in total

Review 1.  The biosynthesis, fate and pharmacological properties of endocannabinoids.

Authors:  V Di Marzo; L De Petrocellis; T Bisogno
Journal:  Handb Exp Pharmacol       Date:  2005

2.  Subacute effects of heavy marihuana smoking on pulmonary function in healthy men.

Authors:  D P Tashkin; B J Shapiro; Y E Lee; C E Harper
Journal:  N Engl J Med       Date:  1976-01-15       Impact factor: 91.245

3.  Effects of long-term cannabis use on selective attention: an event-related potential study.

Authors:  N Solowij; P T Michie; A M Fox
Journal:  Pharmacol Biochem Behav       Date:  1991-11       Impact factor: 3.533

4.  Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up.

Authors:  Ruud van Winkel
Journal:  Arch Gen Psychiatry       Date:  2010-11-01

5.  Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia.

Authors:  Killian A Welch; Andrew C Stanfield; Andrew M McIntosh; Heather C Whalley; Dominic E Job; Thomas W Moorhead; David G C Owens; Stephen M Lawrie; Eve C Johnstone
Journal:  Br J Psychiatry       Date:  2011-09-08       Impact factor: 9.319

Review 6.  Effects of marijuana on pregnancy and fetal development in the human.

Authors:  K Tennes
Journal:  NIDA Res Monogr       Date:  1984

7.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

Review 8.  Cannabis use and earlier onset of psychosis: a systematic meta-analysis.

Authors:  Matthew Large; Swapnil Sharma; Michael T Compton; Tim Slade; Olav Nielssen
Journal:  Arch Gen Psychiatry       Date:  2011-02-07

9.  Comparative effects of alcohol and marijuana on mood, memory, and performance.

Authors:  S J Heishman; K Arasteh; M L Stitzer
Journal:  Pharmacol Biochem Behav       Date:  1997-09       Impact factor: 3.533

Review 10.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

View more
  21 in total

1.  How does state marijuana policy affect US youth? Medical marijuana laws, marijuana use and perceived harmfulness: 1991-2014.

Authors:  Katherine M Keyes; Melanie Wall; Magdalena Cerdá; John Schulenberg; Patrick M O'Malley; Sandro Galea; Tianshu Feng; Deborah S Hasin
Journal:  Addiction       Date:  2016-08-26       Impact factor: 6.526

2.  Trends in use of marijuana and attitudes toward marijuana among youth before and after decriminalization: the case of California 2007-2013.

Authors:  Richard A Miech; Lloyd Johnston; Patrick M O'Malley; Jerald G Bachman; John Schulenberg; Megan E Patrick
Journal:  Int J Drug Policy       Date:  2015-01-14

Review 3.  Reward, Control & Decision-Making in Cannabis Use Disorder: Insights from Functional MRI.

Authors:  Hudaisa Fatima; Allyn C Howlett; Christopher T Whitlow
Journal:  Br J Radiol       Date:  2019-08-09       Impact factor: 3.039

4.  Don't Let Medicine in Missouri Go to Pot: Oppose Sham Medical Marijuana Referenda on November 2018 Ballot.

Authors:  John C Hagan
Journal:  Mo Med       Date:  2018 Sep-Oct

5.  Adolescent cannabis use: changing minds.

Authors:  Andrea Lynne Taylor; Patrick J Lustman; Rhonda Finney; Neda Svrakic; Dragan M Svrakic
Journal:  Mo Med       Date:  2012 Nov-Dec

Review 6.  Medical and recreational marijuana: commentary and review of the literature.

Authors:  Samuel T Wilkinson
Journal:  Mo Med       Date:  2013 Nov-Dec

7.  Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts.

Authors:  Mohammad Hajizadeh
Journal:  Int J Health Policy Manag       Date:  2016-08-01

8.  Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study.

Authors:  Li-Tzy Wu; Kathleen T Brady; Paolo Mannelli; Therese K Killeen
Journal:  J Psychiatr Res       Date:  2013-12-01       Impact factor: 4.791

Review 9.  Emerging issues for our nation's health: the intersection of marijuana use and cardiometabolic disease risk.

Authors:  Denise C Vidot; Guillermo Prado; WayWay M Hlaing; Kristopher L Arheart; Sarah E Messiah
Journal:  J Addict Dis       Date:  2014

Review 10.  Cannabinoid exposure during pregnancy and its impact on immune function.

Authors:  Catherine Dong; Jingwen Chen; Amy Harrington; K Yaragudri Vinod; Muralidhar L Hegde; Venkatesh L Hegde
Journal:  Cell Mol Life Sci       Date:  2018-10-29       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.